Mercados españoles cerrados

Shanghai Pharmaceuticals Holding Co., Ltd (SHPMF)

OTC Markets OTCPK - OTC Markets OTCPK Precio demorado. Divisa en USD
Añadir a la lista de favoritos
1,47000,0000 (0,00%)
Al cierre: 01:20PM EDT

Shanghai Pharmaceuticals Holding Co., Ltd

Shanghai Pharmaceutical Building
No. 200 Taicang Road
Shanghai 200020
China
86 21 6373 0908
https://www.sphchina.com

Sector(es)Healthcare
SectorMedical Distribution
Empleados a tiempo completo48.164

Ejecutivos clave

NombreTítuloPagaEjecutadoAño de nacimiento
Mr. Qiuhua YangExecutive ChairmanN/AN/A1972
Mr. Bo ShenPresident, CFO, Head of the Accounting Department & Executive Director793,41kN/A1973
Mr. Yongzhong LiVP & Executive Director848,14kN/A1970
Mr. Ming DongExecutive DirectorN/AN/A1976
Mr. Tao ZhongVP, Board Secretary & Joint Company SecretaryN/AN/A1972
Mr. Dongming LiVice PresidentN/AN/A1969
Ms. Shuai ShaoVice PresidentN/AN/A1988
Dr. Shunjiang YuChief Medical OfficerN/AN/AN/A
Ms. Pui Kiu WongJoint Company SecretaryN/AN/AN/A
Ying KeDirector & General Manager of R&D Management CenterN/AN/AN/A
Los importes son a partir de 31 de diciembre de 2023 y los valores de compensación son para el último año fiscal que finaliza en esa fecha. Paga es el salario, las bonificaciones, etc. Ejecutado es el valor de las opciones ejecutadas durante el año fiscal. Divisa en USD.

Descripción

Shanghai Pharmaceuticals Holding Co., Ltd. engages research, development, manufacture, distribution, and retailing of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including digestive system, immune metabolism, motor neuron disease, endocrinology, cardiovascular, psychoneurotic, neoplasm, autoimmunity, systemic anti-infection, mental nerve, anti-tumor, oncology, respiratory system, nervous system, auto-immunity, hypertension, neuromyelitis, diabetes, anticholinesterase, polypeptide hormones uterine tonic, antihistamine, anti-inflammatory, anesthetic, immunomodulatory, antiviral, reflux esophagitis, analgesics, weight management, malignant peritoneal effusion, ulcerative colitis, myasthenia gravis, burn injury, anticoagulant, anti-epileptic, anticonvulsant, Alzheimer's, and inflammatory bowel diseases. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. The company was incorporated in 1994 and is headquartered in Shanghai, China.

Gobierno corporativo

El ISS Governance QualityScore de Shanghai Pharmaceuticals Holding Co., Ltd, a día 1 de junio de 2024, es 8. Las puntuaciones base son Auditoría: 7; Tablero: 10; Derechos de los accionistas: 9; Compensación: 2.

Puntuación de gobierno corporativo cedida por Institutional Shareholder Services (ISS). Las puntuaciones indican un rango decil relativo al índice o región. Una puntuación decil de 1 indica un menor riesgo de gobierno, mientras que un 10 indica un riesgo de gobierno superior.